Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study

To investigate whether diagnostic data from implanted cardiac resynchronization therapy defibrillators (CRT‐Ds) retrieved automatically at 24 h intervals via a Home Monitoring function can enable dynamic prediction of cardiovascular hospitalization and death.

[1]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[2]  Jeroen J. Bax,et al.  2010 Focused Update of ESC Guidelines on device therapy in heart failure , 2010, European journal of heart failure.

[3]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[4]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[5]  E. Soliman,et al.  The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  M. Santini,et al.  Intrathoracic and Ventricular Impedances are Associated with Changes in Ventricular Volume in Patients Receiving Defibrillators for CRT , 2010, Pacing and clinical electrophysiology : PACE.

[7]  K. Dickstein,et al.  Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 , 2009, European journal of heart failure.

[8]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[9]  D. Hettrick,et al.  Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. , 2009, Journal of cardiac failure.

[10]  Haran Burri,et al.  Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  É. Marijon,et al.  Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. , 2009, European heart journal.

[12]  F. Oliva,et al.  Monitoring Intrathoracic Impedance with an Implantable Defibrillator Reduces Hospitalizations in Patients with Heart Failure , 2009, Pacing and clinical electrophysiology : PACE.

[13]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[14]  D. Hettrick,et al.  Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization , 2008, Journal of Interventional Cardiac Electrophysiology.

[15]  D. J. Veldhuisen,et al.  Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT‐HF) ☆ , 2008, European journal of heart failure.

[16]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[17]  Angelo Branzi,et al.  Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives , 2007, Journal of General Internal Medicine.

[18]  Jean-Claude Tardif,et al.  Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.

[19]  G. Breithardt,et al.  Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  Christian Butter,et al.  Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. , 2007, European heart journal.

[21]  R. Small.  Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic. , 2007, The American journal of cardiology.

[22]  Christina Murray,et al.  Use of device diagnostics in the outpatient management of heart failure. , 2007, The American journal of cardiology.

[23]  Li Wang,et al.  Fundamentals of intrathoracic impedance monitoring in heart failure. , 2007, The American journal of cardiology.

[24]  Philippe Ritter,et al.  Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  Cheuk-Man Yu,et al.  Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status , 2007, Current heart failure reports.

[26]  Jeroen J. Bax,et al.  Intrathoracic impedance monitoring to predict decompensated heart failure. , 2007, The American journal of cardiology.

[27]  S. Umemura,et al.  Daily shock impedance measured by implantable cardioverter defibrillator is useful in the management of congestive heart failure. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[28]  Hans Ole Hein,et al.  Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age >or=55 years. , 2006, The American journal of cardiology.

[29]  W. Abraham.  New approaches to monitoring heart failure before symptoms appear. , 2006, Reviews in cardiovascular medicine.

[30]  S. Sack,et al.  Predicting mortality and rehospitalization in heart failure patients with Home Monitoring— , 2006, Clinical Research in Cardiology.

[31]  S. Raj,et al.  Letter regarding article by Adamson et al, "Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device". , 2005, Circulation.

[32]  J. Daubert,et al.  Baseline characteristics of patients recruited into the CARE‐HF study , 2005, European journal of heart failure.

[33]  Xiaozheng Zhang,et al.  Serial Changes in Right Ventricular Apical Pacing Lead Impedance Predict Changes in Left Ventricular Ejection Fraction and Functional Class in Heart Failure Patients , 2005, Pacing and clinical electrophysiology : PACE.

[34]  W. Abraham,et al.  Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.

[35]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[36]  L. Rydén,et al.  Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. , 2003, Journal of the American College of Cardiology.

[37]  A. Dyer,et al.  Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. , 1999, American journal of epidemiology.

[38]  H. Crijns,et al.  Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. , 1994, European heart journal.

[39]  M. J. D. Powell,et al.  An efficient method for finding the minimum of a function of several variables without calculating derivatives , 1964, Comput. J..